Related Experiment Video
Updated: Jul 18, 2026

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
Published on: January 3, 2015
Modeling non-random deletions in cancer
Maria Kost-Alimova1, Stefan Imreh
1Karolinska Institutet, Microbiology Tumor and Cell Biology Center (MTC), Box 280, 171 77 Stockholm, Sweden.
Abstract:
Chromosome deletions do abound in cancer and are detected in certain regions in a non-random manner. Although their relevance remains elusive, it is a general agreement that segmental losses provide the cell with selective growth advantage. Consequently these may contain genes and/or regulatory sequences that control normal growth and inhibit malignancy. We have developed a monochromosomal hybrid based experimental model for the generation and functional analysis of deletions, that is called "elimination test" (Et). Focused on human chromosome 3 - that was known to carry multiple 3p deletions - the Et was expected to restrict a 3p tumor suppressor region to a sufficiently small segment that permits the selection of a critically important candidate gene. Surprisingly, we detected three regions that were lost in all or majority of tumors: CER1 (3p21.3, Mb: 43.32-45.74), CER2 (3p22, Mb: 37.83-39.06) and FER (3p14.3-p21.2, Mb: 50.12-58.03). In contrast a 3q26-qter region (CRR) was regularly retained. CER1 - our main focus - contains multiple genes that may inhibit tumor growth, but 3 genes, RIS1, LF (LTF) and LIMD1 have already the necessary experimental support to be considered bona fide tumor suppressors. Tumor suppressor region borders display instability features including: (1) they break in evolution and in tumors, (2) they evolve horizontally, and (3) they are enriched with pseudogene insertions. The most remarkable features at the breakpoint cluster regions were segmental duplications that drive horizontal evolution and contribute to cancer associated instability.
Insights
Chromosome deletions in cancer often lead to growth advantages. Researchers used an elimination test (Et) to identify critical tumor suppressor genes on chromosome 3, pinpointing three key deletion regions.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Chromosome deletions are common in cancer and non-randomly located.
- Segmental losses are believed to confer a selective growth advantage to cancer cells.
- These deletions may harbor genes that regulate normal growth and suppress malignancy.
Purpose of the Study:
- To develop an experimental model, the elimination test (Et), for generating and analyzing chromosome deletions.
- To functionally analyze deletions on human chromosome 3, focusing on the 3p region known for tumor suppressor activity.
- To narrow down the 3p tumor suppressor region and identify candidate genes crucial for inhibiting cancer growth.
Main Methods:
- Development of a monochromosomal hybrid-based experimental model called the "elimination test" (Et).
- Application of the Et to human chromosome 3 to analyze 3p deletions.
- Identification and characterization of frequently deleted regions (CER1, CER2, FER) and a retained region (CRR).
Main Results:
- Three critical deletion regions (CER1, CER2, FER) on chromosome 3p were identified in tumors.
- A 3q26-qter region (CRR) was consistently retained across tumors.
- CER1 contains potential tumor suppressor genes, with RIS1, LF (LTF), and LIMD1 showing strong evidence of tumor suppressor activity.
- Breakpoint regions exhibit instability features like evolutionary breaks, horizontal evolution, and pseudogene insertions, driven by segmental duplications.
Conclusions:
- The elimination test (Et) is effective for identifying tumor suppressor regions and candidate genes.
- Specific regions on chromosome 3p (CER1, CER2, FER) are critical in cancer development.
- Tumor suppressor region borders are unstable and prone to alterations, contributing to cancer-associated genomic instability.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Survival Analysis

